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1. Introduction 
There has been considerable speculation on the 
biologically active conformations of the enkephalins 
and their possible structural similarity to the opiates 
[l-4]. A number of models have been proposed on 
the basis of theoretical calculations [2] and computer 
modelling [3]. Recent NMR studies suggest a high 
degree of conformational flexibility at Gly* and Gly’ 
implying that a favoured conformation does not exist 
in aqueous solution [5]. The replacement of the Gly 
residues by Aib residues will greatly restrict the avail- 
able conformations at positions 2 and 3 of the penta- 
peptides and may thereby allow a better definition of 
the steric requirements for biological activity. This 
approach appears particularly attractive in view of 
the extremely well defined conformations adopted by 
Aib containing peptides [6-lo]. An earlier report 
described the synthesis of Aib*-Met’--enkephalin- 
amide [ 111. Here we present the preparation and 
compare the biological properties of the Aib*, Aib3 
and Aib2-Aib’ Met’--enkephalin derivatives. The 
properties of 3-nitro-Tyr analogs, designed to bind 
paramagnetic NMR shift probes and a fluorescent 
Aib* analog developed for studies of receptor interac- 
tions, are also described. 
2. Experimental procedures 
Peptides listed in table 1 were synthesised by solu- 
tion phase methods using DCC or DCC/ l-hydroxy- 
Abbreviations: Aib, a-aminoisobutyryl; Boc, t-butyloxy- 
carbonyl; DCC, dicyclohexylcarbodiimide; DNS, l-dimethyl- 
aminonaphthalene-5-sulfonyl; TLC, thin-layer chromatography 
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benzotriazole-mediated couplings. Boc groups and 
methyl esters were used for amino and carboxyl 
protection, respectively. Removal was effected with 
HCl-tetrahydrofuran or trifluoroacetic acid for Boc 
groups and saponification in 2 N NaOH-CH30H for 
the esters. Analogs with Aib at residue 2 (2 3 6 7) ,‘,‘W’ 
were prepared by 2t3 condensation, while GlyZY 
analogs (1 4 5) were obtained by 1 t4 coupling. The ,‘W’, 
DNS group was introduced by coupling Boc-Met to 
DNS-NH-CH2-CH2-NH2 [ 121 followed by Boc 
removal and condensation with Boc-Gly-Phe to 
yield the fluorescent tripeptide fragment. The 3-nitro- 
Tyr and DNS analogs (5 6 7) were purified by prepar- ,‘,‘.W 
ative TLC on silica gel using 8:2 CHCI,-CH,OH for 5 
and 6 and 9: 1 CHC13-CH,OH for 7. All analogs were 
checked for homogeneity by TLC Gn silica gel using 
8:2 CHC13-CH30H or 4: 1: 1 n-butanol-water-acetic 
acid systems. Faint iodine positive but ninhydrin- 
negative spots with higher RF were present in 2 and 
3. 1 2 5 6 and 1 gave 270 MHz ‘H NMR spectra fully * ,‘_‘_‘W 
consistent with their structures, while 3 and ,4 yielded 
satisfactory 60 MHz spectra. 
The biological activity of enkephalin analogs was 
tested by microinjection of the peptides into the 
lateral ventricle of the brain of adult albino mice in 
groups of 4. Mice were anaesthetised by brief exposure 
to ether prior to injection. The control mice received 
an equal volume of the diluents, alcohol and water 
without the peptide. Alcohol was necessary to solu- 
bilise certain analogs at neutral pH. Injection of 
enkephalins immediately immobilised the mice and 
also had a pronounced sedative effect. The mice 
assumed abnormal postures during the period of 
sedation, salivated profusely and in a few teeth chat- 
tering was evident. Subsequently the mice overcame 
271 
Volume 106, number 2 FEBS LETTERS October 1979 
Table 1 
Effect of enkephalin analogs on mice 
Samples injecteda Dose 
(fig) 
Mean recovery 
time (minIb 
Control (1:7 alcohol-water) 
Control (1: 2 alcohol-water) 
Tyr-Gly-Gly-Phe-Leu-NH, 1, 
Tyr-Aib-Gly-Phe-Met-NH, ‘i. 
Tyr-Aib-Aib-Phe-Met-NH, 3 
Tyr-Gly-Aib-Phe-Met-NH, 7. 
(3-NOJTyr-Gly-Gly-Phe-Me?-NH, 5 
(3-NO,)Tyr-Aib-Gly-Phe-Met-NH, g 
Tyr-Aib-Gly-Phe-Met-NH-fCH&-%NS 7 
- 2 
_ 4 
100 43 
50 140 
50 140 
100 21 
100 2.5 
100 63 
50 100 
a Injected volumes were 6 ~1 except for 2 where it was 3 ~1. All samples were 
injected in 1:7 alcohol-water solutionyexcept 7 which was dissolved in 1: 2 
alcohol-water 
b Recovery times are averaged for groups of 4 mice 
this effect but appeared drowsy and moved very 
sluggishly or in jerks with a completely inactive or 
limping hind leg. A time lag persisted before the mice 
attained normal coordinated limb movement. In the 
present investigation the biological activity of the 
various analogs was monitored by comparing the 
recovery time of the mice from the effect of enke- 
phalins. Recovery time is the interval that lapses 
from the point of administration of the enkephalins 
to the complete recovery of the mice, as judged by 
the attainment of normal coordinated movement of 
the limbs, as seen in normal mice. 
3. Results and discussion 
Table 1 summarises the biological activity of the 
peptides, as measured by the recovery of coordinated 
movement in mice. It has earlier been demonstrated 
that direct injection of ~~ndorph~ into the brain of 
rats results in marked behavioral effects. Enhanced 
salivation [13], pronounced sedation and a state of 
immobility without motor paralysis [13-l 51 have 
been observed. The state of catatonia was reversed by 
the opiate antagonist, naloxone [ 141. We have there- 
fore chosen to follow the mean recovery time for 
normal movement, after direct injection into the 
brain of mice, as a parameter for comparing the 
activity of the synthetic peptides. The results in 
table 1 clearly demonstrate that the Aib’ and Aib’- 
Aibs 3 analogs are significantly more active than 
~u5-enkeph~inamide 1. The replacement of Met’ 
for Leu’ has only a small effect on activity. While all 
peptides were tested upto a concentration of 100 rug, 
the injection of 2 at these levels led to death of the 
animal. Consequently the more active analogs were 
also examined at the lower dose of 50 pg. 
The pronounced enhancement in the activity of 
the enkephalins on replacement of Gly’ and Gly3 by 
Aib residues suggests that the active conformations 
of the natural peptides are indeed accessible to the 
more hindered synthetic analogs. Earlier studies have 
established the tendency of Aib residues to initiate 
P-turns [6-lo]. X-Ray diffraction [6-83, infrared 
[9] and NMR [lo] studies have shown that 
-Aib-Aib- and -Aib-X- sequences favour @turn 
structures, stabilised by intramolecular 4 + 1 hydrogen 
bonds, in non-aqueous solution. Theoretical studies 
suggest hat 6, J/ values [I6 ] close to the 3re and 
o-helical regions of the conformational map are pre- 
ferred for Aib residues [ 17,183. An examination of 
crystal structures of Aib containing peptides 
[6-8,19,20] yielded a total of 11 Aib residues all 
of which had 4, J/ values confined to the regions 
cp -60 * 20*, $J -30 + 20° or 41 t60 + 20”, 
J/ t30 _+ 20”. It is therefore likely that the Aib 
analogs adopt a well defined backbone conforma- 
tion. Preliminary evidence for a 4 f 1 hydrogen bond 
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in 2 involving the C=O group of Tyr’ and the N-H 
gr&p of Phe4 has been obtained from ‘H NMR. The 
temperature coefficient of the Phe NH chemical shift 
in (CD&SO is found to be 2.77 X 10m3 ppm/% 
whereas the corresponding values for the Gly-NH 
and Met-NHgroupsare 5.55 X low3 and463 X low3 
ppmf”C, respectively. The value obtained for Phe NH 
in Met’-enkephalinamide is 4.63 X 10e3 ppm/*C 
(T. S. Sudha, unpublished results). Interestingly, such 
a hydrogen bond is indeed observed in the crystal 
structure of Leu’--enkephalin, with conformational 
angles of 4 = 59”, $ = 25”, # = 97” and $ = -7O, for 
residues 2 and 3 1211. These values are generally 
stereochemically favourable for D-amino acids and 
the optically inactive Aib residues can indeed adopt 
these values. The &turn has also been proposed in 
earlier studies [11. 
The conformations possible for the Aib’-Aib3 
analog 3 are further restricted relative to 2. The 
drama& enhancement in biological act&y of 3 
compared to i suggests hat the active conformations 
may require values of (p2, $2 and #s, 3/s in the range 
Q, = +60 + 30’ and $ = +30 It 30”. The choice of the 
positive 9, $ values is made in view of the very low 
receptor affinity of L-Ala2-enkephalinamide com- 
pared to the D-Ala2 or Gly’ peptides [22]. Studies 
fitting the enkephalin structure to a proposed opiate 
pharmacophore suggested a biologically active con- 
formation having e2 = 160”, $2 = -87”, #s = -118” 
and $3 = 98” [3]. These values represent significantly 
higher energy confo~ations for both 2, and 2. It is 
unlikely that favourable receptor interactions will 
offset this destabilisation. Modelling studies have also 
predicted that the Aib3 analog 4 will be inactive [23]. 
The results in table 1 show that 4 possesses substantial 
activity, though in this test system the activity is lower 
than Leus-enkephalinamide. From conformational 
considerations the high activity of the derivatives 1, 
ZJ, and 3 implies that 4 should also exhibit activit< 
In view-of the ~own~ability of the Tyrr-Gly2 bond 
to enzymatic degradation [22] a direct comparison 
of the analogs with Aib2 and Gly’ may not be strictly 
valid, under the conditions of testing. 
The binding of metal atoms at specific sites in bio- 
molecules permits application of the NMR shift probe 
method to the study of solution conformations in 
aqueous olution [24]. It has been proposed that 
3-nitro-Tyr can serve as a metal binding site in pro- 
teins [25] and an application of the method to the 
study of bovine pancreatic trypsin inhibitor has been 
reported [26]. In order to explore the potential of 
this method we have synthesised the nitrotyrosine 
analogs 5and 6. It is seen from table 1 that introduc- 
tion of &ro g;bup or&o to the phenolic hydroxyl, 
reduces activity by a factor of two compared to 1 
and 2. The retention of substantial ctivity sugge<ts 
that the nitro group does not completely impede the 
receptor interaction of the phenolic sidechain. The 
ortho nitro group would also reduce the pK, of the 
phenol from a value of 10.1 in Tyr to a value of 7.2 
in nitrotyrosine [27]. As a consequence ionisation 
of the phenolic function is possible at physiologic~ 
PH. Whether such a process is responsible for the 
observed attenuation in activity remains to be estab- 
lished. Preliminary NMR studies uggest a gross overall 
conformational similarity between 2 and 2. The 
nitrotyrosine derivative may therefore be used to 
further develop details of the three-dimensional struc- 
ture of the Aib’ analogs in solution. 
Fluorescent enkeph~in derivatives may prove 
useful in probing opiate receptors and enkephalin 
binding sites in subcellular f actions from brain tissue. 
Table 1 shows that introduction of a dansyl group, 
coupled via an ethylene-diamine spacer to the Met’ 
carboxyl group leads to an active, fluorescent deriva- 
tive 1. This derivative may also be used to probe 
molecular conformation by monitoring energy trans- 
fer f4] from Tyr’ to the dansyl moiety. During the 
course of our studies a report on the synthesis of 
active fluorescent analogs of the Gly’-Gly3 and 
D-Ala2-Gly3 Met5-enkephalins appeared [28]. A 
comparison of energy transfer efficiencies in the Gly2 
and Aib’ derivatives may yield further information 
on peptide folding. Detailed conformational nalysis 
of the peptides reported here together with a more 
comprehensive study of their biological activity may 
be of value in establishing structure-function correla- 
tions for the enkephalins. 
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